Dr. McGovern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St
3910 Building, 2nd Floor
Philadelphia, PA 19104Phone+1 215-662-9990Fax+1 215-243-4658
Education & Training
University of Pennsylvania Health SystemFellowship, Infectious Disease, 1999 - 2001- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
Northwestern University The Feinberg School of MedicineClass of 1996
Certifications & Licensure
PA State Medical License 1998 - 2024
Publications & Presentations
PubMed
- Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complic...Greg Moeck, Leanne B Gasink, Rodrigo E Mendes, Leah N Woosley, MaryBeth Dorr
Antimicrobial Agents and Chemotherapy. 2024-07-09 - 6 citationsEfficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs.Gregory J Moran, Surya Chitra, Paul C McGovern
Infectious Diseases and Therapy. 2022-02-01 - 6 citationsEfficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study.Julio Ramirez, Daniel Deck, Paul B. Eckburg, Marla Curran, Anita Das
Open Forum Infectious Diseases. 2021-06-01
Press Mentions
FDA Accepts New Antibiotic Combo for Priority Review for Complicated UTIAugust 16th, 2023- FDA OKs Priority Review for Antibiotic Combo for Complicated UTIsAugust 23rd, 2023
- Novel Antibiotic Combo Bests Meropenem for Complicated UTIsFebruary 15th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
